-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
[Pharmaceutical Network Market Analysis] Traditional Chinese medicine formula granules are popular in the market due to their convenience in taking and carrying, and the market size is continuing to expand
.
The pilot work of traditional Chinese medicine formula granules has ended on November 1, 2021, which also means that the traditional Chinese medicine formula granule industry has entered a new stage, with both opportunities and challenges
.
On the one hand, traditional Chinese medicine formula granules are open to all medical institutions, which is beneficial to the entire industry, and the market is expected to continue to expand; on the other hand, with the liberalization of policies, it means that in addition to the six pilot enterprises, there will be more companies entering the traditional Chinese medicine formula granule industry.
, market competition will also intensify
.
In this context, how should companies respond? The author has learned that some companies have already taken relevant measures to embrace opportunities while also actively responding to challenges
.
Under the background of coexistence of opportunities and challenges, Hongri Pharmaceutical's 2021 annual report shows that the company is guided by market demand, strengthens the planning work in the layout of Chinese herbal medicine planting bases, production capacity layout, quality control, etc.
, and cooperates with supply, The whole chain of research, production and sales is closely coordinated, and the system is linked, so as to do a good job in process control and quality control, and consolidate the first-mover advantage
.
At the same time, actively participate in the formulation of national standards, promote inclusion in the provincial standard system, and seize industry opportunities
.
In addition, the company establishes a price early warning mechanism through market surveys, controls procurement nodes, avoids the impact of price fluctuations, and actively implements cost management and precise delivery to reduce the overall cost of the entire industry chain
.
China Resources Sanjiu Traditional Chinese Medicine Formula Granules is also a development business of China Resources Sanjiu.
The company produces more than 600 kinds of single-flavor formula granules
.
In the context of the ever-changing environment in the pharmaceutical industry, the company continues to carry out innovation, transformation and upgrading, strengthen brand and channel construction, increase innovation investment, improve operational quality and efficiency, and stabilize its position in the industry.
In 2021, the company achieved an operating income of 15.
320 billion yuan, a year-on-year increase of 12.
34%.
%
.
Among them, the business of traditional Chinese medicine formula granules achieved rapid growth
.
It is reported that for the business of traditional Chinese medicine formula granules, CR Sanjiu actively responded to the industry changes brought about by the end of the pilot program, explored the value of traditional Chinese medicine by relying on the core concepts of traditional Chinese medicine, established a traceability system covering the whole process of medicinal material planting, traditional Chinese medicine decoction pieces, and formula granules, and continuously improved the formula.
The production efficiency and quality control level of granules shall be accelerated, the construction of standardized planting bases of medicinal materials shall be accelerated, and the advantages of medicinal materials shall be established from the source
.
In terms of the production of formula granules, the company has accelerated the production and implementation of varieties that have promulgated national standards and local standards, completed the digital transformation of production plants in multiple locations through intelligent manufacturing projects, and achieved large-scale, batch, high-quality, and highly flexible cross-regional digitalization workshop
.
In addition, in terms of marketing and promotion, the company has explored and developed a series of traditional Chinese medicine health products by consolidating the core market, accelerating the expansion of the grassroots medical market and the decoction pieces market
.
Conclusion Judging from the measures taken by the above-mentioned pharmaceutical companies, they are mainly to reduce costs and ensure quality through the layout of Chinese herbal medicine planting bases, quality control, establishment of a price warning mechanism, and acceleration of digital transformation
.
The industry pointed out that the modernization of traditional Chinese medicine is inseparable from intelligent manufacturing.
As the coordinates of the modernization of traditional Chinese medicine, traditional Chinese medicine formula granules need to speed up the transformation of "intelligent manufacturing", so as to realize the quality traceability of traditional Chinese medicine materials, the "digitization" of the production process, and the visualization of monitoring, so as to ensure the traditional Chinese medicine formula granules.
Consistency of quality and stability of curative effect protect patients' rights and health
.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
.
.
The pilot work of traditional Chinese medicine formula granules has ended on November 1, 2021, which also means that the traditional Chinese medicine formula granule industry has entered a new stage, with both opportunities and challenges
.
On the one hand, traditional Chinese medicine formula granules are open to all medical institutions, which is beneficial to the entire industry, and the market is expected to continue to expand; on the other hand, with the liberalization of policies, it means that in addition to the six pilot enterprises, there will be more companies entering the traditional Chinese medicine formula granule industry.
, market competition will also intensify
.
In this context, how should companies respond? The author has learned that some companies have already taken relevant measures to embrace opportunities while also actively responding to challenges
.
Under the background of coexistence of opportunities and challenges, Hongri Pharmaceutical's 2021 annual report shows that the company is guided by market demand, strengthens the planning work in the layout of Chinese herbal medicine planting bases, production capacity layout, quality control, etc.
, and cooperates with supply, The whole chain of research, production and sales is closely coordinated, and the system is linked, so as to do a good job in process control and quality control, and consolidate the first-mover advantage
.
At the same time, actively participate in the formulation of national standards, promote inclusion in the provincial standard system, and seize industry opportunities
.
In addition, the company establishes a price early warning mechanism through market surveys, controls procurement nodes, avoids the impact of price fluctuations, and actively implements cost management and precise delivery to reduce the overall cost of the entire industry chain
.
China Resources Sanjiu Traditional Chinese Medicine Formula Granules is also a development business of China Resources Sanjiu.
The company produces more than 600 kinds of single-flavor formula granules
.
In the context of the ever-changing environment in the pharmaceutical industry, the company continues to carry out innovation, transformation and upgrading, strengthen brand and channel construction, increase innovation investment, improve operational quality and efficiency, and stabilize its position in the industry.
In 2021, the company achieved an operating income of 15.
320 billion yuan, a year-on-year increase of 12.
34%.
%
.
Among them, the business of traditional Chinese medicine formula granules achieved rapid growth
.
It is reported that for the business of traditional Chinese medicine formula granules, CR Sanjiu actively responded to the industry changes brought about by the end of the pilot program, explored the value of traditional Chinese medicine by relying on the core concepts of traditional Chinese medicine, established a traceability system covering the whole process of medicinal material planting, traditional Chinese medicine decoction pieces, and formula granules, and continuously improved the formula.
The production efficiency and quality control level of granules shall be accelerated, the construction of standardized planting bases of medicinal materials shall be accelerated, and the advantages of medicinal materials shall be established from the source
.
In terms of the production of formula granules, the company has accelerated the production and implementation of varieties that have promulgated national standards and local standards, completed the digital transformation of production plants in multiple locations through intelligent manufacturing projects, and achieved large-scale, batch, high-quality, and highly flexible cross-regional digitalization workshop
.
In addition, in terms of marketing and promotion, the company has explored and developed a series of traditional Chinese medicine health products by consolidating the core market, accelerating the expansion of the grassroots medical market and the decoction pieces market
.
Conclusion Judging from the measures taken by the above-mentioned pharmaceutical companies, they are mainly to reduce costs and ensure quality through the layout of Chinese herbal medicine planting bases, quality control, establishment of a price warning mechanism, and acceleration of digital transformation
.
The industry pointed out that the modernization of traditional Chinese medicine is inseparable from intelligent manufacturing.
As the coordinates of the modernization of traditional Chinese medicine, traditional Chinese medicine formula granules need to speed up the transformation of "intelligent manufacturing", so as to realize the quality traceability of traditional Chinese medicine materials, the "digitization" of the production process, and the visualization of monitoring, so as to ensure the traditional Chinese medicine formula granules.
Consistency of quality and stability of curative effect protect patients' rights and health
.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
.
